How to use targeted mass spectrometry to validate PTMs?
Post-Translational Modifications (PTMs) are key mechanisms in regulating core life processes such as cell fate, signal transduction, and metabolic balance. Common modifications include phosphorylation, acetylation, ubiquitination, and methylation. Although high-throughput mass spectrometry (e.g., DDA and DIA) has been widely used for the initial screening of PTM sites, targeted mass spectrometry is still required in the subsequent verification and quantification stages to achieve higher specificity and sensitivity.
I. What is targeted mass spectrometry? Why is it suitable for PTM verification?
Targeted mass spectrometry is a quantitative mass spectrometry method that targets known peptides with predefined detection parameters. It mainly consists of two types:
- SRM/MRM (Selected/Multiple Reaction Monitoring): Based on a triple quadrupole platform, suitable for high-throughput, multi-target verification.
- PRM (Parallel Reaction Monitoring): Based on high-resolution mass spectrometry (e.g., Orbitrap), which can simultaneously collect all fragment ions, resulting in more accurate quantification and strong anti-interference ability.
The core advantages of targeted mass spectrometry are:
- High specificity: By precisely setting mass-to-charge ratios and fragment ion information, background interference is reduced.
- Strong sensitivity: Suitable for detecting low-abundance PTM peptides.
- Good reproducibility: Suitable for large samples, clinical cohorts, or mechanistic validation studies.
Therefore, targeted mass spectrometry has become a crucial bridge from 'site discovery' to 'mechanism elucidation.'
II. Standard process for PTM verification using targeted mass spectrometry
The successful application of targeted mass spectrometry relies on scientifically reasonable experimental design and technical execution. Here are six recommended standard steps, each directly impacting data reliability and repeatability:
1. Discovery phase: Identify the modification sites of interest.
Typically, non-targeted mass spectrometry techniques (such as DDA or DIA) are used for initial screening to obtain possible modification peptides and site information. For example, potential pS/pT/pY sites are identified in whole proteome or phosphoproteome analyses.
2. Design and synthesis of isotope-labeled peptide standards
To achieve accurate quantification, stable isotope-labeled peptides (Heavy Peptides) need to be synthesized for the modification peptides of interest. Design considerations include:
Accurate localization of modification sites;
(1) Moderate peptide length (generally 8–20 amino acids);
(2) Avoiding amino acid combinations that are easily oxidized or difficult to ionize as much as possible.
(3) Labeled peptides are used for subsequent quantification calibration and method development to ensure the accuracy of detection signals.
3. Method development and optimization
This is the most critical step in targeted mass spectrometry, aiming to establish a detection method with good linearity, accuracy, and sensitivity. Main components include:
(1) Fragment ion screening (Transitions): Selecting high-response, high-specificity fragments for SRM/MRM;
(2) Retention time window (RT) optimization: Enhancing the accuracy of peak recognition;
(3) Ion pair intensity ordering: Ensuring that main/auxiliary ion pairs have good peak shapes;
(4) Linear range and LOD/LOQ testing: Evaluating quantification ability and determining the minimum detection limit.
4. Sample preparation and modified peptide enrichment
Due to the often extremely low abundance of PTM peptides, specific enrichment techniques for modifications are commonly used to enhance signals, such as:
(1) Phosphorylation: IMAC, TiO₂, Fe-NTA;
(2) Acetylation/Methylation: Antibody affinity purification;
(3) Ubiquitination: K-ε-GG antibody enrichment.
Additionally, standardizing the pretreatment process of proteins/peptides (e.g., denaturation, reduction, alkylation, enzymatic digestion) is necessary to ensure reproducibility.
5. Targeted mass spectrometry detection
Apply the developed method to experimental samples for detection. Key technical points include:
(1) Using an equimolar amount of labeled peptides as a reference with endogenous peptides;
(2) Avoiding batch effects between samples, and introducing QC samples is recommended;
(3) Performing peak recognition, integration, and quantitative comparison for each peptide;
(4) Conducting CV evaluations for multiple repetitions to ensure method stability.
PRM is particularly suitable for multi-site parallel monitoring and can achieve ppb-level detection sensitivity on the Orbitrap platform.
6. Data analysis and biological interpretation
Mass spectrometry data analysis goes beyond comparing signal intensities and delves into the biological level, such as:
(1) Comparing relative changes in modification levels between different treatment groups;
(2) Evaluating whether modifications independently regulate by combining protein abundance information;
(3) Using pathway enrichment and network analysis to identify key regulatory nodes;
(4) Verifying whether modification changes are functionally relevant or disease-associated.
III. Biotree Biotech: Supporting high-confidence PTM research
At Biotree Biotech, we provide an integrated service system from PTM screening to targeted verification for our clients, covering the following core capabilities:
- Multiple modification site enrichment schemes (phosphorylation, acetylation, ubiquitination, etc.)
- High-resolution targeted platforms (Orbitrap) supporting PRM/BoxCar strategies
- Our self-built PTM labeled peptide library shortens the project cycle.
- Standardization of quality control and data analysis processes to meet the requirements for SCI publication or drug development
We have successfully provided personalized PTM quantitative analysis services for multiple universities and biopharmaceutical companies, assisting research results to be published in top international journals such as Nature Communications, Cell Reports, and Science Advances.
As a core mechanism of precise regulation, post-translational modifications are increasingly gaining attention in basic and translational research. In the PTM research chain, validation is a critical step towards mechanism analysis and functional research. Targeted mass spectrometry, with its high specificity, strong sensitivity, quantifiability, and good reproducibility, has become the 'gold standard' for validating modification sites. If you are conducting PTM-related research or planning to expand modification studies to functional mechanisms or clinical biomarker development, feel free to contact Biotech-Pack Biotech. We are committed to accelerating your research progress and enhancing data reliability with our professional technology and research experience.
Biotech-Pack Biotech -- A quality service provider for bioproduct characterization and multi-omics mass spectrometry detection
Related services:
How to order?
